The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Viral evasion and subversion of pattern-recognition receptor signalling
Open accessAbstract
The expression of pattern-recognition receptors (PRRs) by immune and tissue cells provides the host with the ability to detect and respond to infection by viruses and other microorganisms. Significant progress has been made from studying this area, including the identification of PRRs, such as Toll-like receptors and RIG-I-like receptors, and the description of the molecular basis of their signalling pathways, which lead to the production of interferons and other cytokines. In parallel, common mechanisms used by viruses to evade PRR-mediated responses or to actively subvert these pathways for their own benefit are emerging. Accumulating evidence on how viral infection and PRR signalling pathways intersect is providing further insights into the function of the pathways involved, their constituent proteins and ways in which they could be manipulated therapeutically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Ishikawa, H., & Barber, G. N. (2008) · Nature · doi:10.1038/nature07317 · Cited by 3,576
Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329 · cited 1×
“IPS1 resides at the outer mitochondrial membrane and interacts with RIG-I and MDA5 through its CARD.”
BackgroundApproaching the Asymptote? Evolution and Revolution in Immunology
Janeway, C. A. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,252
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667
Self-citationIPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562
5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling
Xu, L.-G., Wang, Y.-Y., Han, K.-J., Li, L.-Y., Zhai, Z., & Shu, H.-B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.014 · Cited by 1,853
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response
Takaoka, A., Wang, Z., Choi, M. K., Yanai, H., Negishi, H., Ban, T., Lu, Y., Miyagishi, M., Kodama, T., Honda, K., et al. (2007) · Nature · doi:10.1038/nature06013 · Cited by 1,715
Yoneyama, M., Kikuchi, M., Matsumoto, K., Imaizumi, T., Miyagishi, M., Taira, K., Foy, E., Loo, Y.-M., Gale, M., Akira, S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2851 · Cited by 1,689
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
Kurt-Jones, E. A., Popova, L., Kwinn, L., Haynes, L. M., Jones, L. P., Tripp, R. A., Walsh, E. E., Freeman, M. W., Golenbock, D. T., Anderson, L. J., et al. (2000) · Nature Immunology · doi:10.1038/80833 · Cited by 1,683
Kato, H., Takeuchi, O., Mikamo-Satoh, E., Hirai, R., Kawai, T., Matsushita, K., Hiiragi, A., Dermody, T. S., Fujita, T., & Akira, S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080091 · Cited by 1,599
Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
Lund, J., Sato, A., Akira, S., Medzhitov, R., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030162 · Cited by 1,198
Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R. A., Diamond, M. S., & Colonna, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603082103 · Cited by 1,169
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis
Wang, T., Town, T., Alexopoulou, L., Anderson, J. F., Fikrig, E., & Flavell, R. A. (2004) · Nature Medicine · doi:10.1038/nm1140 · Cited by 1,155
Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
Zhang, S.-Y., Jouanguy, E., Ugolini, S., Smahi, A., Elain, G., Romero, P., Segal, D., Sancho-Shimizu, V., Lorenzo, L., Puel, A., et al. (2007) · Science · doi:10.1126/science.1139522 · Cited by 1,057
Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune Response
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.003 · Cited by 1,008
Andrejeva, J., Childs, K. S., Young, D. F., Carlos, T. S., Stock, N., Goodbourn, S., & Randall, R. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407639101 · Cited by 992
Weber, F., Wagner, V., Rasmussen, S. B., Hartmann, R., & Paludan, S. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.5059-5064.2006 · Cited by 954
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
Gale, M. J., Korth, M. J., Tang, N. M., Tan, S.-L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R., & Katze, M. G. (1997) · Virology · doi:10.1006/viro.1997.8493 · Cited by 810
A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA
Ishii, K. J., Coban, C., Kato, H., Takahashi, K., Torii, Y., Takeshita, F., Ludwig, H., Sutter, G., Suzuki, K., Hemmi, H., et al. (2006) · Nature Immunology · doi:10.1038/ni1282 · Cited by 775
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA
Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J., & Gale, M. (2008) · Nature · doi:10.1038/nature07106 · Cited by 744
Plotch, S. J., Bouloy, M., Ulmanen, I., & Krug, R. M. (1981) · Cell · doi:10.1016/0092-8674(81)90449-9 · Cited by 713
Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., & Colonna, M. (2004) · Blood · doi:10.1182/blood-2003-08-2674 · Cited by 695
TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines
Ishii, K. J., Kawagoe, T., Koyama, S., Matsui, K., Kumar, H., Kawai, T., Uematsu, S., Takeuchi, O., Takeshita, F., Coban, C., et al. (2008) · Nature · doi:10.1038/nature06537 · Cited by 628
Mibayashi, M., Martínez-Sobrido, L., Loo, Y.-M., Cárdenas, W. B., Gale, M., & García-Sastre, A. (2007) · Journal of Virology · doi:10.1128/jvi.01265-06 · Cited by 576
MDA5/RIG-I and virus recognition
Takeuchi, O., & Akira, S. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.01.002 · Cited by 570
Requirement of DDX3 DEAD Box RNA Helicase for HIV-1 Rev-RRE Export Function
Yedavalli, V. S. R. K., Neuveut, C., Chi, Y.-H., Kleiman, L., & Jeang, K.-T. (2004) · Cell · doi:10.1016/j.cell.2004.09.029 · Cited by 549
Resolution of a chronic viral infection after interleukin-10 receptor blockade
Ejrnaes, M., Filippi, C. M., Martinic, M. M., Ling, E. M., Togher, L. M., Crotty, S., & von Herrath, M. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061462 · Cited by 548
Carty, M., Goodbody, R., Schröder, M., Stack, J., Moynagh, P. N., & Bowie, A. G. (2006) · Nature Immunology · doi:10.1038/ni1382 · Cited by 539
Self-citationGoffic, R. L., Balloy, V., Lagranderie, M., Alexopoulou, L., Escriou, N., Flavell, R., Chignard, M., & Si-Tahar, M. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020053 · Cited by 514
The C-Terminal Regulatory Domain Is the RNA 5′-Triphosphate Sensor of RIG-I
Cui, S., Eisenächer, K., Kirchhofer, A., Brzózka, K., Lammens, A., Lammens, K., Fujita, T., Conzelmann, K.-K., Krug, A., & Hopfner, K.-P. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.10.032 · Cited by 499
Chang, H. W., Watson, J. C., & Jacobs, B. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4825 · Cited by 483
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling
Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K., & O'Neill, L. A. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160027697 · Cited by 466
Self-citationCárdenas, W. B., Loo, Y.-M., Gale, M., Hartman, A. L., Kimberlin, C. R., Martínez-Sobrido, L., Saphire, E. O., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02199-05 · Cited by 453
Fragments of the HIV-1 Tat Protein Specifically Biand TAR RNA
Weeks, K. M., Ampe, C., Schultz, S. C., Steitz, T. A., & Crothers, D. M. (1990) · Science · doi:10.1126/science.2205002 · Cited by 444
Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2
Kawagoe, T., Sato, S., Matsushita, K., Kato, H., Matsui, K., Kumagai, Y., Saitoh, T., Kawai, T., Takeuchi, O., & Akira, S. (2008) · Nature Immunology · doi:10.1038/ni.1606 · Cited by 442
A protein covalently linked to poliovirus genome RNA.
Lee, Y. F., Nomoto, A., Detjen, B. M., & Wimmer, E. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.1.59 · Cited by 432
Devaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704870200 · Cited by 411
Cirl, C., Wieser, A., Yadav, M., Duerr, S., Schubert, S., Fischer, H., Stappert, D., Wantia, N., Rodriguez, N., Wagner, H., et al. (2008) · Nature Medicine · doi:10.1038/nm1734 · Cited by 393
Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection
Loo, Y.-M., Owen, D. M., Li, K., Erickson, A. K., Johnson, C. L., Fish, P. M., Carney, D. S., Wang, T., Ishida, H., Yoneyama, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601523103 · Cited by 391
Hepatitis C virus NS5A: tales of a promiscuous protein
Macdonald, A., & Harris, M. (2004) · Journal of General Virology · doi:10.1099/vir.0.80204-0 · Cited by 388
Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε‐mediated IRF activation
Schröder, M., Baran, M., & Bowie, A. G. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.143 · Cited by 375
Self-citationThe Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense
Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A., & O'Neill, L. A. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021652 · Cited by 370
Self-citationStack, J., Haga, I. R., Schröder, M., Bartlett, N. W., Maloney, G., Reading, P. C., Fitzgerald, K. A., Smith, G. L., & Bowie, A. G. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041442 · Cited by 369
Self-citationDoes Toll-like receptor 3 play a biological role in virus infections?
Edelmann, K. H., Richardson-Burns, S., Alexopoulou, L., Tyler, K. L., Flavell, R. A., & Oldstone, M. B. A. (2004) · Virology · doi:10.1016/j.virol.2004.01.033 · Cited by 354
Flanegan, J. B., Petterson, R. F., Ambros, V, Hewlett, N. J., & Baltimore, D. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.3.961 · Cited by 347
Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules
Wang, Z., Choi, M. K., Ban, T., Yanai, H., Negishi, H., Lu, Y., Tamura, T., Takaoka, A., Nishikura, K., & Taniguchi, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801295105 · Cited by 336
Habjan, M., Andersson, I., Klingström, J., Schümann, M., Martin, A., Zimmermann, P., Wagner, V., Pichlmair, A., Schneider, U., Mühlberger, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002032 · Cited by 331
O'Neill, L. A. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.06.004 · Cited by 330
Soulat, D., Bürckstümmer, T., Westermayer, S., Goncalves, A., Bauch, A., Stefanovic, A., Hantschel, O., Bennett, K. L., Decker, T., & Superti-Furga, G. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.126 · Cited by 325
Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3
Vercammen, E., Staal, J., & Beyaert, R. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-07 · Cited by 323
Brzózka, K., Finke, S., & Conzelmann, K.-K. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7673-7681.2005 · Cited by 321
Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor
Yang, Y., Liang, Y., Qu, L., Chen, Z., Yi, M., Li, K., & Lemon, S. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611506104 · Cited by 320
The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing
Haasnoot, J., de Vries, W., Geutjes, E.-J., Prins, M., de Haan, P., & Berkhout, B. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030086 · Cited by 317
TRADD Protein Is an Essential Component of the RIG-like Helicase Antiviral Pathway
Michallet, M.-C., Meylan, E., Ermolaeva, M. A., Vazquez, J., Rebsamen, M., Curran, J., Poeck, H., Bscheider, M., Hartmann, G., König, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.013 · Cited by 306
Ermolaeva, M. A., Michallet, M.-C., Papadopoulou, N., Utermöhlen, O., Kranidioti, K., Kollias, G., Tschopp, J., & Pasparakis, M. (2008) · Nature Immunology · doi:10.1038/ni.1638 · Cited by 281
Okabe, Y., Kawane, K., Akira, S., Taniguchi, T., & Nagata, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051654 · Cited by 275
DDX3 DEAD-Box RNA Helicase Is Required for Hepatitis C Virus RNA Replication
Ariumi, Y., Kuroki, M., Abe, K.-I., Dansako, H., Ikeda, M., Wakita, T., & Kato, N. (2007) · Journal of Virology · doi:10.1128/jvi.01517-07 · Cited by 255
Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses
Hiscott, J., Nguyen, T.-L. A., Arguello, M., Nakhaei, P., & Paz, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209941 · Cited by 247
DiPerna, G., Stack, J., Bowie, A. G., Boyd, A., Kotwal, G., Zhang, Z., Arvikar, S., Latz, E., Fitzgerald, K. A., & Marshall, W. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400567200 · Cited by 233
Self-citationTLR3 in antiviral immunity: key player or bystander?
Schröder, M., & Bowie, A. G. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.07.002 · Cited by 226
Self-citationPobezinskaya, Y. L., Kim, Y.-S., Choksi, S., Morgan, M. J., Li, T., Liu, C., & Liu, Z. (2008) · Nature Immunology · doi:10.1038/ni.1639 · Cited by 216
Lin, R., Lacoste, J., Nakhaei, P., Sun, Q., Yang, L., Paz, S., Wilkinson, P., Julkunen, I., Vitour, D., Meurs, E., et al. (2006) · Journal of Virology · doi:10.1128/jvi.02495-05 · Cited by 216
Lin, R., Genin, P., Mamane, Y., Sgarbanti, M., Battistini, A., Harrington, W. J., Barber, G. N., & Hiscott, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204163 · Cited by 212
Keating, S. E., Maloney, G. M., Moran, E. M., & Bowie, A. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705266200 · Cited by 210
Self-citationBauhofer, O., Summerfield, A., Sakoda, Y., Tratschin, J.-D., Hofmann, M. A., & Ruggli, N. (2007) · Journal of Virology · doi:10.1128/jvi.02032-06 · Cited by 205
Barro, M., & Patton, J. T. (2007) · Journal of Virology · doi:10.1128/jvi.02498-06 · Cited by 205
Genetic analysis of resistance to viral infection
Beutler, B., Eidenschenk, C., Crozat, K., Imler, J.-L., Takeuchi, O., Hoffmann, J. A., & Akira, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2174 · Cited by 195
West Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal Transduction
Wilson, J. R., de Sessions, P. F., Leon, M. A., & Scholle, F. (2008) · Journal of Virology · doi:10.1128/jvi.00226-08 · Cited by 194
Binding of influenza A virus NS1 protein to dsRNA in vitro
Hatada, E., & Fukuda, R. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-12-3325 · Cited by 193
MDA-5 Is Cleaved in Poliovirus-Infected Cells
Barral, P. M., Morrison, J. M., Drahos, J., Gupta, P., Sarkar, D., Fisher, P. B., & Racaniello, V. R. (2007) · Journal of Virology · doi:10.1128/jvi.01360-06 · Cited by 193
Romano, P. R., Zhang, F., Tan, S.-L., Garcia-Barrio, M. T., Katze, M. G., Dever, T. E., & Hinnebusch, A. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7304 · Cited by 188
Awomoyi, A. A., Rallabhandi, P., Pollin, T. I., Lorenz, E., Sztein, M. B., Boukhvalova, M. S., Hemming, V. G., Blanco, J. C. G., & Vogel, S. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3171 · Cited by 182
Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases
Quintana-Murci, L., Alcaïs, A., Abel, L., & Casanova, J.-L. (2007) · Nature Immunology · doi:10.1038/ni1535 · Cited by 181
Melroe, G. T., Silva, L., Schaffer, P. A., & Knipe, D. M. (2006) · Virology · doi:10.1016/j.virol.2006.10.028 · Cited by 174
Newman, R. M., Salunkhe, P., Godzik, A., & Reed, J. C. (2006) · Infection and Immunity · doi:10.1128/iai.74.1.594-601.2006 · Cited by 172
Abe, T., Kaname, Y., Hamamoto, I., Tsuda, Y., Wen, X., Taguwa, S., Moriishi, K., Takeuchi, O., Kawai, T., Kanto, T., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00649-07 · Cited by 167
HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation
Okumura, A., Alce, T., Lubyova, B., Ezelle, H., Strebel, K., & Pitha, P. M. (2008) · Virology · doi:10.1016/j.virol.2007.10.042 · Cited by 166
Vaccinia Virus E3 Protein Prevents the Antiviral Action of ISG15
Guerra, S., Cáceres, A., Knobeloch, K., Horak, I. D., & Estéban, M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000096 · Cited by 164
Differential recognition of double-stranded RNA by RIG-I–like receptors in antiviral immunity
Saito, T., & Gale, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081210 · Cited by 160
Nociari, M., Ocheretina, O., Schoggins, J. W., & Falck-Pedersen, E. (2007) · Journal of Virology · doi:10.1128/jvi.02685-06 · Cited by 159
Inhibition of IκB Kinase by Vaccinia Virus Virulence Factor B14
Chen, R. A.-J., Ryzhakov, G., Cooray, S., Randow, F., & Smith, G. L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040022 · Cited by 155
Subversion of the innate immune system by a retrovirus
Jude, B. A., Pobezinskaya, E. L., Bishop, J. L., Parke, S., Medzhitov, R. M., Chervonsky, A. V., & Golovkina, T. V. (2003) · Nature Immunology · doi:10.1038/ni926 · Cited by 153
Alff, P. J., Gavrilovskaya, I. N., Gorbunova, E. E., Endriss, K., Chong, Y., Geimonen, E., Sen, N., Reich, N. C., & Mackow, E. R. (2006) · Journal of Virology · doi:10.1128/jvi.00508-06 · Cited by 153
Brand, S. R., Kobayashi, R., & Mathews, M. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8388 · Cited by 147
Immunopathology of highly virulent pathogens: insights from Ebola virus
Zampieri, C. A., Sullivan, N. J., & Nabel, G. J. (2007) · Nature Immunology · doi:10.1038/ni1519 · Cited by 146
Joo, C. H., Shin, Y. C., Gack, M. U., Wu, L., Levy, D. E., & Jung, J. U. (2007) · Journal of Virology · doi:10.1128/jvi.00235-07 · Cited by 142
Jung, A., Kato, H., Kumagai, Y., Kumar, H., Kawai, T., Takeuchi, O., & Akira, S. (2007) · Journal of Virology · doi:10.1128/jvi.01640-07 · Cited by 140
Saira, K., Zhou, Y., & Jones, C. (2007) · Journal of Virology · doi:10.1128/jvi.02064-06 · Cited by 137
TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection
Gowen, B. B., Hoopes, J. D., Wong, M., Jung, K., Isakson, K. C., Alexopoulou, L., Flavell, R. A., & Sidwell, R. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6301 · Cited by 131
ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation.
Lu, G., Reinert, J. T., Pitha, I., Okumura, A., Kellum, M. J., Knobeloch, K., Hassel, B., & Pitha, P. M. (2006) · PubMed · Cited by 129
Otsuka, M., Kato, N., Moriyama, M., Taniguchi, H., Wang, Y., Dharel, N., Kawabe, T., & Omata, M. (2005) · Hepatology · doi:10.1002/hep.20666 · Cited by 129
Unterstab, G., Ludwig, S., Anton, A., Planz, O., Dauber, B., Krappmann, D., Heins, G., Ehrhardt, C., & Wolff, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502883102 · Cited by 114
Hartman, A. L., Ling, L., Nichol, S. T., & Hibberd, M. L. (2008) · Journal of Virology · doi:10.1128/jvi.00215-08 · Cited by 106
Alff, P. J., Sen, N., Gorbunova, E. E., Gavrilovskaya, I. N., & Mackow, E. R. (2008) · Journal of Virology · doi:10.1128/jvi.00290-08 · Cited by 104
Evasion of innate immunity by vaccinia virus
Haga, I. R., & Bowie, A. (2005) · Parasitology · doi:10.1017/s0031182005008127 · Cited by 101
Self-citationStructures of TLR–ligand complexes
Jin, M. S., & Lee, J. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.002 · Cited by 100
TLR3 Increases Disease Morbidity and Mortality from Vaccinia Infection
Hutchens, M. A., Luker, K. E., Sottile, P. D., Sonstein, J., Lukacs, N. W., Núñez, G., Curtis, J. L., & Luker, G. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.483 · Cited by 98
Lu, L. L., Puri, M., Horvath, C. M., & Sen, G. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710089200 · Cited by 96
Mechanism of Inactivation of NF-κB by a Viral Homologue of IκBα
Tait, S. W. G., Reid, E., Greaves, D. R., Wileman, T. E., & Powell, P. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000320200 · Cited by 91
Johnson, C., Owen, D. M., & Gale, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610361200 · Cited by 90
Lefort, S., Soucy-Faulkner, A., Grandvaux, N., & Flamand, L. (2007) · Journal of Virology · doi:10.1128/jvi.00183-07 · Cited by 84
Maloney, G., Schröder, M., & Bowie, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501917200 · Cited by 75
Self-citationDatta, A., Sinha-Datta, U., Dhillon, N. K., Buch, S. J., & Nicot, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600684200 · Cited by 72
African Swine Fever Virus IAP-Like Protein Induces the Activation of Nuclear Factor Kappa B
Rodríguez, C. I., Nogal, M. L., Carrascosa, Á. L., Salas, M. L., Fresno, M., & Revilla, Y. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3936-3942.2002 · Cited by 67
Bowie, A. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03301.x · Cited by 64
Self-citationMatta, H., Mazzacurati, L., Schamus, S., Yang, T., Sun, Q., & Chaudhary, P. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700118200 · Cited by 51
Viral interference with IL-1 and Toll signaling
Janeway, C. A., & Medzhitov, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10682 · Cited by 23
Innate Immune Signaling Pathways: Lessons from Vaccinia Virus
Hurst, T. P., & Bowie, A. (2008) · Future Virology · doi:10.2217/17460794.3.2.147 · Cited by 1
Self-citation
Cited by
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
Kaczmarek, A., Vandenabeele, P., & Krysko, D. V. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.003 · Cited by 1,411
Mitochondria in innate immune responses
West, A. P., Shadel, G. S., & Ghosh, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2975 · Cited by 1,376
Lipid Nanoparticle Systems for Enabling Gene Therapies
Cullis, P. R., & Hope, M. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.013 · Cited by 1,208
Proal, A. D., & VanElzakker, M. B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.698169 · Cited by 876
Metadata
- Authors
- Bowie, A. G., & Unterholzner, L.
- Venue
- Nature Reviews Immunology
- Published
- 2008-12
- Volume
- 8
- Issue
- 12
- Pages
- 911-922
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2017161741
- Cited by
- 746
- References
- 117
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.